Posts Categorized: MS News

£2 million of new MS research

Source MS Society: We’re proud to announce that 11 new projects have secured funding through our 2016 grant round. From investigating if a stroke drug could repair damage caused in MS to testing the benefits of specialist rehab, these projects cover a wide range of topics.  Read on.

Don’t forget your Flu Jab

Don’t forget your Flu Jab Source NHS: Stay well this Winter – make sure you get your flu jab.  For more information click here.

Potential Therapy, Laquinimod, Shows Promise as Progressive MS Treatment in Mouse Study.

Potential Therapy, Laquinimod, Shows Promise as Progressive MS Treatment in Mouse Study. Source Multiple Sclerosis News Today: The experimental therapy laquinimod was seen to prevent the start of harmful immune responses and to disrupt the progression of multiple sclerosis (MS) in a mouse model of the disease. This finding may be especially promising, as the… Read more »

MS Drug could reverse physical symptoms

Source Medical News Today: A drug that treats relapsing-remitting multiple sclerosis – a form of multiple sclerosis that accounts for around 85 percent of people with the condition – has been revealed to reverse some of the damage caused by the disease. This revelation may have implications for future therapeutic strategies for people with the… Read more »

DMTs can reverse MS symptoms for some people

Source MS Society: Disease modifying treatments (DMTs) may be able to reverse the symptoms caused by MS for some people with relapsing MS. This is according to new research published in the Journal of Neurology.  Read on.

Need help completing your PIP Form?

 Communicare can help with advice, information and support.: “We can offer assistance with all matters benefits related. We are able to complete benefit checks for you to assess what benefits you are entitled to and what level of payment you can expect. We can assist you with benefit claims, both on-line applications and paper applications. We… Read more »

Antioxidant Lipoic Acid Appears to Slow SPMS Patients’ Neurodegeneration

Source Multiple Sclerosis News Today: A pilot study exploring the antioxidant lipoic acid in patients with secondary progressive multiple sclerosis (SPMS) demonstrated that treatment for two years reduced the speed of brain tissue loss and improved the patients’ walking speed.  Read on.

More than £10 million to be spent on progressive MS research

Source MS Society: The International Progressive MS Alliance has awarded three £3.6 million grants to researchers accelerating the pace of progressive MS research. The Alliance is a worldwide collaborative of MS organisations co-founded by the MS Society. More than 2.3 million people around the world live with MS and more than one million of those… Read more »

Half of people with MS have faced ‘unacceptable’ mistreatment

Source MS Society: Almost half (45%) of people with MS feel they have experienced mistreatment or stigma because of their symptoms, according to our most recent survey. Our report showed that 49% of people with MS have been accused of being drunk because they were having trouble walking. Another 47% say they’ve been told they… Read more »